Proteinuria Global Clinical Trials Review, H2, 2015

1
Proteinuria Global Clinical Trials Review, H2,
2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Proteinuria Global Clinical Trials Review, H2,
  2015 provides an overview of Proteinuria clinical
  trials scenario. This report provides top line
  data relating to the clinical trials on
  Proteinuria. Report includes an overview of trial
  numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) .
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/protei
  nuria-global-clinical-trials-review-h2-2015-market
  

3


Table of Content
Table of Contents 2List of Tables 4List of
Figures 5Introduction 6Proteinuria 6Report
Guidance 6Clinical Trials by Region 7Clinical
Trials and Average Enrollment by Country 8Top
Five Countries Contributing to Clinical Trials in
Asia-Pacific 10Top Five Countries Contributing
to Clinical Trials in Europe 11Top Countries
Contributing to Clinical Trials in North America
12Top Countries Contributing to Clinical Trials
in Middle East and Africa 13Top Five Countries
Contributing to Clinical Trials in Central and
South America 14Clinical Trials by G7 Countries
Proportion of Proteinuria to Genito Urinary
System And Sex Hormones Clinical Trials
15Clinical Trials by Phase in G7 Countries
16Clinical Trials in G7 Countries by Trial
Status 17Clinical Trials by E7 Countries
Proportion of Proteinuria to Genito Urinary
System And Sex Hormones Clinical Trials
18Clinical Trials by Phase in E7 Countries
19Clinical Trials in E7 Countries by Trial
Status 20Clinical Trials by Phase 21
4


Table of Content
In Progress Trials by Phase 22Clinical Trials by
Trial Status 23Clinical Trials by End Point
Status 24Unaccomplished Trials of Proteinuria
25Subjects Recruited Over a Period of Time
28Clinical Trials by Sponsor Type 29Prominent
Sponsors 30Top Companies Participating in
Proteinuria Therapeutics Clinical Trials
31Prominent Drugs 32Clinical Trial Profiles
33Clinical Trial Overview of Top Companies
33Novartis AG 33Clinical Trial Overview of
Novartis AG 33Merck Co., Inc. 34Clinical
Trial Overview of Merck Co., Inc.
34Mallinckrodt Plc 35Clinical Trial Overview of
Mallinckrodt Plc 35GlaxoSmithKline Plc
36Clinical Trial Overview of GlaxoSmithKline Plc
36 Enquire At http//www.researchbeam.com/prote
inuria-global-clinical-trials-review-h2-2015-marke
t/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/proteinuria-global-cli
nical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com